Hormonal Contraceptives Market

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency & Pricing
    1.5 Limitation
    1.6 Stakeholders

2 Research Methodology
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation Methodology
    2.4 Market Forecast Methodology
    2.5 Market Data Validation and Data Triangulation
    2.6 Assumptions

3 Executive Summary
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
           5.3.2 Restraints
           5.3.3 Opportunities
           5.3.4 Challenges

6 Hormonal Contraceptives Market, By Method
    6.1 Introduction
    6.2 Combined Oral Contraceptives
    6.3 Oral Contraceptives
    6.4 Implanted Contraceptives
    6.5 Injected Contraceptives
    6.6 Intrauterine
    6.7 Trasdermal Patch
    6.8 Vaginal Ring

7 Hormonal Contraceptives Market, By Hormones
    7.1 Introduction
    7.2 Androgens
    7.3 Estrogens
    7.4 Progestogens
    7.5 Gonadotropins
    7.6 Antiandrogens
    7.7 Others

8 Hormonal Contraceptivesmarket, By End-Users
    8.1 Introduction
    8.2 Hospitals
    8.3 Homecare
    8.4 Gynecology Centers
    8.5 Clinics
    8.6 Ambulatory Surgical Centers (ASC)

9 Hormonal Contraceptives Market, By Geography
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
    9.4 Asia-Pacific
    9.5 Rest of the World

10 Competitive Landscape
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Situation and Trends
             10.3.1 New Product Launches
             10.3.2 Expansions
             10.3.3 Agreements, Partnerships, and Collborations
             10.3.4 Acquisitions
             10.3.5 Others

11 Company Profiles
(Overview, Financials, Products & Services, Strategy, & Developments)*
     11.1 Introduction
     11.2 Amgen
     11.3 Bayer Healthcare Pharmaceuticals
     11.4 Cipla Limited
     11.5 Glenmark Pharmaceuticals
     11.6 Lupin Pharmaceuticals, Inc.
     11.7 Novartis AG
     11.8 Pfizer, Inc.
     11.9 Piramal Healthcare Limited
     11.10 Sun Pharmaceutical Industries Ltd.
     11.11 Teva Pharmaceutical Industries

12 Appendix
     12.1 Discussion Guide
     12.2 Introducing Rt: Real-Time Market Intelligence
     12.3 Available Customizations
     12.4 Related Reports

Note:
1. All the Above Markets Will Be Provided for the Years 2014, 2015, 2016, and 2021
2. Revenue for Companies Listed Under “Company Profile” Section (Chapter 10) Might Not Be Captured for Companies Whose Financial Data is Not Available in Public Domain
3. The Above Scope is Tentative and is Subject to Change as the Research Progresses